Crown Laboratories Acquires Aesthetics Eclipse’s Aesthetics Portfolio
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
The agency is seeking public comment on a proposal to classify bemotrizinol as generally recognized as safe and effective for over-the-counter sunscreens.